Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
36.49
0.98 (2.76%)
At close: Sep 26, 2025, 3:59 PM
36.02
-1.29%
After-hours: Sep 26, 2025, 06:45 PM EDT
Kiniksa Pharmaceuticals Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 156.8M | 137.78M | 201.42M | 112.21M | 103.39M | 78.89M | 136.02M | 64.8M | 54.49M | 42.66M | 39.94M | 33.42M | 26.97M | 22.19M |
| Product Revenue Growth | +13.80% | -31.59% | +79.50% | +8.53% | +31.07% | -42.01% | +109.90% | +18.91% | +27.75% | +6.81% | +19.49% | +23.92% | +21.56% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 46.86M | 43.53M | 40.53M | 46.4M | 42.4M | 38.68M | 36.74M | 34.47M | 29.18M | 29.05M | 27.21M | 24.68M | 23.84M | 22.22M | 22.74M | 20.76M | 21.85M | 20.6M | 15.5M | 11.8M | 9.54M | 8.49M | 9.7M | 8.43M | 8.44M | 8.39M | 8.01M | 5.51M | 4.33M | 3.71M | 2.78M | 2.24M | 2.12M | 1.9M |
| Selling, General, and Administrative Revenue Growth | +7.66% | +7.39% | -12.64% | +9.44% | +9.60% | +5.29% | +6.59% | +18.14% | +0.45% | +6.72% | +10.28% | +3.51% | +7.30% | -2.30% | +9.55% | -4.98% | +6.06% | +32.90% | +31.37% | +23.73% | +12.37% | -12.47% | +14.98% | -0.11% | +0.56% | +4.75% | +45.29% | +27.46% | +16.63% | +33.45% | +24.05% | +5.71% | +11.40% | n/a |
| Research and Development Revenue | 18.75M | 19.32M | 35.22M | 26.06M | 23.9M | 26.18M | 19.82M | 17.11M | 23.77M | 15.17M | 14.39M | 16.48M | 13.8M | 20.82M | 27.43M | 19.24M | 23.95M | 28.68M | 37.4M | 31.42M | 22.32M | 20.9M | 22.89M | 22.01M | 30.85M | 59.25M | 36.12M | 20.64M | 17.2M | 12.63M | 29.93M | 14.01M | 9.27M | 3.15M |
| Research and Development Revenue Growth | -2.96% | -45.12% | +35.15% | +9.03% | -8.72% | +32.12% | +15.84% | -28.03% | +56.65% | +5.43% | -12.71% | +19.47% | -33.72% | -24.12% | +42.61% | -19.67% | -16.52% | -23.30% | +19.03% | +40.74% | +6.81% | -8.67% | +3.96% | -28.64% | -47.94% | +64.04% | +74.98% | +20.02% | +36.18% | -57.80% | +113.67% | +51.08% | +194.82% | n/a |